Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
3.360
+0.010 (0.30%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $18.18 million as of October 9, 2026. It is the 37,842nd most valuable company in the world and the 5,303rd biggest in the United States. Its market cap has decreased by 58.02% in one year.
Market Cap
18.18M
Enterprise Value
-1.65M
1-Year Change
-58.02%
Global Rank
Country Rank
#5,303 United States
Category
ChartMarket Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $18.18M, an increase of 68.53%. That is a compound annual growth rate of 33.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 18.18M | -12.85% |
| Dec 31, 2025 | 20.86M | 273.80% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Akari Therapeutics, | 19.97M |
| Psyence Biomedical | 19.05M |
| Jasper Therapeutics | 18.78M |
| NewcelX | 17.44M |
| Dyadic International | 17.05M |
| Palatin Technologies | 16.38M |
| BioCardia | 16.12M |
| Kiora Pharmaceuticals | 16.10M |